Community/Retail

I hate seeing summer end, but a certain distraction takes me right to the middle of February without even missing it.

Price Chopper is selling plush primates and fundraising through a month-long pin-up campaign to raise money for St. Jude Children's Research Hospital.

Pharmacy Week is a time to celebrate one of the best professions in health care.

You don't have to be an expert in automation to know that technology is catching up with pharmacy.

Medline Industries is voluntarily recalling 1 lot of acetaminophen tablets.

A recent high-profile case of a celebrity allegedly indulging in "Herbal Viagra" and cocaine highlights an overlooked problem.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), discusses what pharmacists need to know about the memorandum of understanding regarding the interstate shipment of compounds.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses the nuances between a pharmacist's method of intervention versus the practices of other health providers.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, forecasts several different innovative solutions that are poised to drive better medication adherence over the next 2-3 years.

If all individuals with diabetic retinopathy were treated in a timely manner, the incidence of blindness from diabetes could be decreased by 90%.

Rural and cancer hospitals will no longer have access to 340B discount pricing for orphan drug purchases.

The FDA today has granted accelerated approval to Boehringer Ingelheim's intravenous solution idarucizumab (Praxbind) for the rapid reversal of Pradaxa.

ASHP announced today that it is extremely disappointed in the recent court decision by the U.S District Court for the District of Columbia that will exclude all drugs with an "orphan" designation from the 340B Drug Pricing Program for rural and cancer hospitals.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses how provider status would allow pharmacists to optimize their time and better support medication adherence for patients.

Daiichi Sankyo will reorganize its US Commercial organization as it begins to transition from a maturing primary care product portfolio to a differentiated specialty portfolio.

Synjardy, a type 2 diabetes treatment, is now available by prescription in US pharmacies.

The FDA has launched its "Fresh Empire" national public education campaign in an effort to prevent and reduce tobacco use among multicultural youth.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Black children with severe pain are less likely to receive opioids in emergency rooms than white children.

With OTC remedies for colds crowding self-help shelves, experts are divided on the merits of single-symptom treatment over multi-symptom therapy.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some of the DEA's requirements for handling controlled substances.

In recognition of American Pharmacists Month, Mel Seabright, PharmD, MBA, shares how he became a pharmacist.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, outlines several ways in which Rite Aid demonstrates its commitment to the pharmacist's role in direct patient care.

Many pharmacists are looking to national certification as a standard by which to accurately discern a pharmacy technician's knowledge.

Ron Lanton, government affairs strategist for the Pharmacy Podcast Show, interviews Phil LaFoy of Blount Specialty Pharmacy.

340B Health is deeply disappointed with a federal district court ruling today that will significantly raise the cost of orphan drugs for rural and cancer hospitals and their patients.

Rite Aid pharmacies nationwide are once again providing free resources to help its senior customers select the right prescription drug plan or update their existing coverage during the annual Medicare Part D enrollment period.

Valeant Pharmaceuticals International has announced the expiration of the tender offer to purchase all of the outstanding shares of Synergetics USA.